Samodelov, Sophia L.
Gai, Zhibo
De Luca, Francesca
Haldimann, Klara
Hobbie, Sven N.
Müller, Daniel
Kullak-Ublick, Gerd A.
Visentin, Michele
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_175639)
UZH Foundation (FK-17-056)
Article History
Received: 22 February 2024
Accepted: 9 July 2024
First Online: 16 July 2024
Competing interests
: S.N.H. is a co-founder and shareholder in Juvabis AG. G.A.K.-U. is employed by Novartis Pharma. The authors declare no conflict of interest.